Invivyd, Inc. (IVVD)Healthcare | Biotechnology | New Haven, United States | NasdaqGM
1.59 USD
-0.09
(-5.357%) ⇩
(April 21, 2026, 4 p.m.
EDT)
After hours: 1.64 +0.05 (3.145%) ⇧ (April 21, 2026, 7:54 p.m. EDT) Short-term: ★★★☆☆ | Long-term: ★★☆☆☆ | Dividends: ☆☆☆☆☆ |
Hot Take | April 18, 2026, 11:50 p.m. EDT
Dataverse (IVVD) is a highly speculative biotech hold with broken fundamentals. Despite analyst 'Strong Buy' ratings stalled by massive downside targets (implied by the lack of specific numerical targets in the data provided vs the high valuation multiples) and earnings risk, the technical setup shows recent resilience above the 100-day average after a significant stock-share offering. Long-term upside depends entirely on the success of their COVID-19 program and upcoming FDA clearances, making it a classic 'cat and mouse' trade for risk-tolerant traders rather than a fundamental investment. |
| Model | MAE |
|---|---|
| MSTL ✓ | 0.230373 |
| AutoARIMA | 0.235210 |
| AutoETS | 0.235211 |
| AutoTheta | 0.235315 |
Forecast horizon: 45 days | Selected: MSTL
| Forecast Reliability | |
|---|---|
| Score | 53% |
| H-stat | 3.09 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.170 |
| Excess Kurtosis | -0.19 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 1.033 |
| Revenue per Share | 0.31 |
| Market Cap | 449,658,176 |
| Forward P/E | -7.23 |
| Beta | 0.74 |
| Profit Margins | -98.25% |
| Website | https://www.invivyd.com |
As of April 18, 2026, 11:50 p.m. EDT: Options flow indicates significant defensive positioning with heavy put volume (particularly at the May 15 expiration and the 0.50 strike in December) compared to a muted call flow. The bullish sentiment relies on high-strike December calls ($7.50 strike) into OTM, while March quotes show aggressive positioning against downside. The data suggests speculators are hedging against a decline or waiting for a binary event, rather than establishing immediate directional beta long positions.
| Attribute | Value |
|---|---|
| 52 Week Change | 1.7272727 |
| Address1 | 209 Church Street |
| All Time High | 78.82 |
| All Time Low | 0.355 |
| Ask | 1.6 |
| Ask Size | 1 |
| Average Analyst Rating | 1.5 - Strong Buy |
| Average Daily Volume10 Day | 4,778,620 |
| Average Daily Volume3 Month | 3,075,849 |
| Average Volume | 3,075,849 |
| Average Volume10Days | 4,778,620 |
| Beta | 0.738 |
| Bid | 1.56 |
| Bid Size | 2 |
| Book Value | 0.857 |
| City | New Haven |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 1.59 |
| Current Ratio | 7.244 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,774,915,200 |
| Day High | 1.69 |
| Day Low | 1.58 |
| Debt To Equity | 1.033 |
| Display Name | Invivyd |
| Earnings Call Timestamp End | 1,772,717,400 |
| Earnings Call Timestamp Start | 1,772,717,400 |
| Earnings Timestamp | 1,772,717,400 |
| Earnings Timestamp End | 1,778,157,000 |
| Earnings Timestamp Start | 1,778,157,000 |
| Ebitda | -54,805,000 |
| Ebitda Margins | -1.02581 |
| Enterprise To Ebitda | -4.108 |
| Enterprise To Revenue | 4.214 |
| Enterprise Value | 225,130,624 |
| Eps Current Year | -0.225 |
| Eps Forward | -0.22 |
| Eps Trailing Twelve Months | -0.28 |
| Esg Populated | 0 |
| Exchange | NGM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 1.5924 |
| Fifty Day Average Change | -0.0023999214 |
| Fifty Day Average Change Percent | -0.0015071097 |
| Fifty Two Week Change Percent | 172.72728 |
| Fifty Two Week High | 3.07 |
| Fifty Two Week High Change | -1.4799999 |
| Fifty Two Week High Change Percent | -0.48208466 |
| Fifty Two Week Low | 0.483 |
| Fifty Two Week Low Change | 1.107 |
| Fifty Two Week Low Change Percent | 2.2919254 |
| Fifty Two Week Range | 0.483 - 3.07 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,628,256,600,000 |
| Float Shares | 167,677,582 |
| Forward Eps | -0.22 |
| Forward P E | -7.227273 |
| Free Cashflow | -38,399,000 |
| Full Exchange Name | NasdaqGM |
| Full Time Employees | 122 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.92987 |
| Gross Profits | 49,679,000 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.07383 |
| Held Percent Institutions | 0.92119 |
| Implied Shares Outstanding | 282,803,863 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | Invivyd, Inc., together with its subsidiaries, engages in the research, development, commercialization, and sale of antibody therapies for the prevention and treatment of viral infectious diseases in the United States. The company offers Pemivibart, a half-life extended investigational monoclonal antibody for the pre-exposure prophylaxis prevention of COVID-19 in adults and adolescents through injection under the PEMGARDA brand. It also develops VYD2311, a monoclonal antibody, which is in Phase III clinical trial for the prevention and treatment of SARS-CoV-2 virus; and VBY329, a monoclonal antibody, which is in pre-clinical trial stage for the prevention and treatment of respiratory syncytial virus and measles in neonates, infants, and children. It has a collaboration agreement with Adimab, LLC for the discovery and optimization of proprietary antibodies. The company was formerly known as Adagio Therapeutics, Inc. and changed its name to Invivyd, Inc. in September 2022. Invivyd, Inc. was incorporated in 2020 and is headquartered in New Haven, Connecticut. |
| Long Name | Invivyd, Inc. |
| Market | us_market |
| Market Cap | 449,658,176 |
| Market State | POSTPOST |
| Max Age | 86,400 |
| Message Board Id | finmb_677282690 |
| Most Recent Quarter | 1,767,139,200 |
| Net Income To Common | -52,489,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 475,110,489 |
| Number Of Analyst Opinions | 3 |
| Open | 1.69 |
| Operating Cashflow | -58,135,000 |
| Operating Margins | -0.72963995 |
| Payout Ratio | 0.0 |
| Phone | 781 819 0080 |
| Post Market Change | 0.049999952 |
| Post Market Change Percent | 3.144651 |
| Post Market Price | 1.64 |
| Post Market Time | 1,776,815,687 |
| Previous Close | 1.68 |
| Price Eps Current Year | -7.066667 |
| Price Hint | 4 |
| Price To Book | 1.8553092 |
| Price To Sales Trailing12 Months | 8.416467 |
| Profit Margins | -0.98246 |
| Quick Ratio | 7.063 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | strong_buy |
| Recommendation Mean | 1.5 |
| Region | US |
| Regular Market Change | -0.0899999 |
| Regular Market Change Percent | -5.35714 |
| Regular Market Day High | 1.69 |
| Regular Market Day Low | 1.58 |
| Regular Market Day Range | 1.58 - 1.69 |
| Regular Market Open | 1.69 |
| Regular Market Previous Close | 1.68 |
| Regular Market Price | 1.59 |
| Regular Market Time | 1,776,801,601 |
| Regular Market Volume | 1,131,868 |
| Return On Assets | -0.17089 |
| Return On Equity | -0.33965 |
| Revenue Growth | 0.245 |
| Revenue Per Share | 0.31 |
| Sand P52 Week Change | 0.34445214 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 282,803,863 |
| Shares Percent Shares Out | 0.0936 |
| Shares Short | 26,469,699 |
| Shares Short Previous Month Date | 1,772,150,400 |
| Shares Short Prior Month | 22,663,061 |
| Short Name | Invivyd, Inc. |
| Short Percent Of Float | 0.1039 |
| Short Ratio | 9.44 |
| Source Interval | 15 |
| State | CT |
| Symbol | IVVD |
| Target High Price | 10.0 |
| Target Low Price | 10.0 |
| Target Mean Price | 10.0 |
| Target Median Price | 10.0 |
| Total Cash | 226,688,992 |
| Total Cash Per Share | 0.802 |
| Total Debt | 2,494,000 |
| Total Revenue | 53,426,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -0.28 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 1.603545 |
| Two Hundred Day Average Change | -0.013544917 |
| Two Hundred Day Average Change Percent | -0.008446858 |
| Type Disp | Equity |
| Volume | 1,131,868 |
| Website | https://www.invivyd.com |
| Zip | 6,510 |